THE GOLD STANDARD IN THIRD-PARTY CERTIFICATION AND TESTING : +1-800-920-6605, info@bscg.org
Apr 26, 2026
Dietary supplement use is prevalent among both elite athletes and the general public. Data from the Anti-Doping Sciences Institute indicate that 93% of elite New Zealand athletes and 73% of U.S. adults consume dietary supplements. In this context, contamination and adulteration are recognized as ongoing issues. A 2023 review reported a 28% average risk of unintentional doping across 50 international surveys due to drug contamination in supplements. Contamination rates for banned steroids in tested supplements range from 12% to 58%. Strict liability standards apply to athletes, military personnel, and first responders, making a single contaminated product capable of ending careers. This review outlines the principles of supplement contamination risk mitigation, identifies contamination origins, and provides guidance for brands and compliance teams on reducing exposure to these risks.
Supplement contamination risk mitigation consists of manufacturing controls, quality systems, and independent testing measures designed to identify and prevent the presence of undeclared drugs, banned substances, and environmental impurities in dietary supplements. This approach addresses both intentional adulteration and unintentional contamination through the management of raw materials, production processes, and supply chains as well as comprehensive finished product testing.
There are two primary sources of contaminants in supplements: adulteration and unintentional contamination. Comprehensive risk management requires an understanding of both mechanisms.
Adulteration denotes the intentional or negligent addition of undeclared substances. Published analyses show that 10% to 30% of supplements in certain categories contain prohibited substances. The U.S. Food and Drug Administration (FDA) has documented more than 1,060 tainted dietary supplements in categories such as muscle-building, sexual enhancement, weight loss, and pain relief. Synthetic steroids and steroidal analogs frequently appear in muscle-building products. Sibutramine is present in approximately 84.9% of adulterated weight-loss supplements according to FDA data spanning a decade, while sildenafil and tadalafil commonly appear in sexual enhancement supplements.
Unintentional contamination arises from process failures or environmental factors rather than deliberate acts. Heavy metals, pesticides, solvents, microbial agents, and pharmaceutical drugs may enter products via deficient raw material controls, inadequate manufacturing segregation, or even compromised water sources. Plant-derived ingredients are a specific concern due to their capacity to accumulate heavy metals and even pharmaceutical drugs from soil or water. Consumer Reports testing identified at least one heavy metal in nearly all of 134 protein supplements tested. Plant-based proteins generally exhibited twice the lead content of whey or egg-derived proteins.
Cross-contamination from equipment use is documented as a risk factor. SARMs and similar banned substances may be processed in facilities where compliant dietary supplements are also produced, increasing the risk of contamination through shared equipment.
Product labels do not always accurately reflect ingredient content. A review by Sport Integrity Australia of 200 uncertified sports supplements obtained online found 35% contained banned substances, with 57% of those lacking disclosure of those substances on the label. Certain label characteristics are associated with elevated risk levels.
Products positioned in high-risk categories, including muscle-building, male performance, pre-workout stimulation, nootropics, or weight loss, display a higher likelihood of contamination with pharmaceutical or designer drugs that are not disclosed on the label.
Additional risk indicators include proprietary blends with undisclosed ingredient quantities, branding that emphasizes botanicals or “natural” labeling while concealing the presence of synthetic substances, and the absence of independent third-party certification. Drug-like naming conventions, claims implying pharmaceutical effects without appropriate disclosures, missing contact information, untraceable brand origins, and pricing significantly below market value have also been associated with substandard quality control.
The BSCG Dietary Supplement Ingredient Advisory List is maintained to catalogue substances sold as supplements that do not appear to conform to legal ingredient standards. Many listed ingredients are investigational or pharmaceutical drugs while others are substances that may be present in botanicals that may be prohibited in sport.
Effective prevention of supplement contamination requires structured control measures throughout all stages of production, not solely at the finished product level.
GMP compliance and facility audits represent foundational components. The Dietary Supplement Health and Education Act (DSHEA) does not require pre-market approval of supplements, resulting in regulatory enforcement that depends on post-market surveillance. Manufacturers bear primary responsibility for product safety and quality. GMP audits serve to verify that operating practices and procedures comply with current Good Manufacturing Practices.
Supplier qualification and raw material controls are critical. Globally distributed supply chains increase adulteration risk. Manufacturers should establish and verify detailed identity, purity, strength, composition and limits on contaminants specifications for all incoming materials, employ risk-based testing frequencies, and conduct increased testing of initial batches from high-risk suppliers compared to established sources with a history of compliance.
Contaminant testing should encompass a broad range of analytes including banned substances or other pharmaceutical drugs. Testing services include analysis of heavy metals (using ICP-MS), microbiological agents, pesticide residues, solvents, or aflatoxins. Each contaminant category requires validated analytical methods tailored to detect specific risks in order to provide verified quality.
Documentation and recall readiness are essential. Effective record-keeping, traceability systems, and comprehensive recall procedures enable prompt response when post-release quality issues are identified. Batch production records and master manufacturing records are required to verify how products are made and what they are made from.
Finished product testing for banned substances is becoming a more essential addition to supplement marketing. For brands and manufacturing facilities looking to avoid contamination of finished products ingredient screening would be a good thing to add to quality control protocols.
While standard quality control testing confirms label claims, it is not designed to detect undeclared drug contaminants. Independent supplement testing complements manufacturer controls by analyzing products for hidden drugs or banned substances in sport at accredited third-party laboratories using validated LC-MS and GC-MS methods with sensitivity in the low to mid parts-per-billion range.
Independent testing programs generally include banned substance panels aligned with the World Anti-Doping Agency (WADA) Prohibited List; these panels may also extend to prescription, over-the-counter, and illicit drugs not specifically addressed by sport regulations. The effectiveness of risk mitigation is influenced by testing frequency; lot-by-lot testing reduces contamination risk with greater reliability than intermittent sampling because frequency correlates with risk reduction.
Internationally recognized certification programs include BSCG Certified Drug Free, NSF Certified for Sport®, Informed Sport, Informed Choice, the Cologne List®, and HASTA™. Each program varies in terms of testing scope, testing frequency, and substances included in their protocols. The BSCG Certified Drug Free program conducts lot-by-lot analysis of finished products for more than 450 substances, including approximately 400 WADA-listed drugs and 50 additional prescription, OTC, or illicit drugs, in ISO 17025 accredited facilities.
The Certified Drug Free program includes a GMP audit requirement, and evaluation of brand level compliance that includes supplier qualification, ingredient specifications, finished product testing, adverse event reporting, and recall procedures.
Public certification databases provide a mechanism for athletes, compliance teams, and consumers to confirm whether specific product or ingredient lots have completed testing. Certification applies solely to tested lots; unlisted lots, even from established brands, present an unmitigated risk profile.
Contamination risks evolve as formulations, suppliers, and designer compounds change over time. Ongoing updates to testing panels ensure coverage of emerging substance classes and analogs. Single-point certification does not address dynamic risk environments.
Lot-by-lot or periodic testing establishes an auditable history of compliance. For manufacturers, this practice lowers liability exposure and recall potential. For regulated professionals, it reduces the likelihood of inadvertent anti-doping rule violations. GMP audits and certification at the facility level facilitates continued adherence to evolving compliance requirements.
Third-party certification supports retail regulatory requirements. For example, Amazon's dietary supplement seller central policies mandate annual contaminant testing for high risk products by ISO 17025 accredited laboratories, pursuant to standards such as NSF/ANSI 173 or USP protocols. Brands participating in recognized certification programs are positioned to satisfy these expectations consistently. The BSCG Certified Drug Free and Certified Quality programs are both part of the Amazon Compliance Fast Track for non high risk dietary supplements.
Multiple independent studies consistently report high rates of supplement contamination. More than one-third of uncertified sports supplements purchased online have contained banned substances. High-risk categories exhibit recurring, documentation-supported issues with contamination and adulteration.
Third-party certification provides a systematic method to address the limitations of standard regulatory oversight. Manufacturers establish robust mitigation strategies by implementing GMP-based quality systems alongside strict supplier qualification processes. These systems require independent, ISO-accredited testing protocols for banned substances and environmental contaminants. Third-party certification programs solidify these efforts by requiring the verification of lot-specific testing results in public databases, thereby establishing a transparent final control before products reach consumers.
Although no independent program guarantees the absolute elimination of risk, comprehensive certification procedures substantially lower the likelihood of contamination. Documented, ongoing oversight establishes an auditable framework that improves the early detection of banned substances or other contaminants and verifies the quality and integrity of finished products. Certification and analytical testing programs facilitate continuous compliance management, functioning as an integrated component of a broader quality control system rather than an isolated intervention.
Athletes, military service members, and first responders should look for third-party certification programs that focus on banned substances in order to avoid inadvertent positive drug tests. It is essential to verify that a lot has been tested by reviewing certification program databases as only certified lots offer protection against contamination with prohibited substances.
Contaminants most commonly enter products via deliberate adulteration, where undeclared drugs are added, or through unintentional contamination arising from raw materials, shared manufacturer equipment, or environmental factors that could lead to the presence of heavy metals, pesticides, or even banned substances.
Banned substances in sport and other drug contaminants have been shown through research studies and marketplace sampling to be a very real concern in dietary supplements. Other potential supplement contaminants include heavy metals, pesticides, microbial agents, solvents, aflatoxins, and pharmaceutical drugs. Label inaccuracies and underdosed formulas also represent established risks, particularly in uncertified or low-cost products.
Third-party certification delivers independent confirmation that a supplement has been tested for banned substances, contaminants, and label accuracy using validated analytical methods in accredited laboratories. This independent mechanism is distinct from routine manufacturer quality control protocols and is a key tool in supplement contamination risk mitigation.
BSCG Certified Drug Free, NSF Certified for Sport®, Informed Sport, Informed Choice, the Cologne List®, and HASTA™ are major international providers of independent third party certification for banned substances. Each program adopts specific protocols that differ in scope, frequency, and panel composition. BSCG Certified Quality and NSF Contents Certified programs conduct annual testing for label claims, heavy metals, microbiological agents, pesticides in herbal products, and banned substances.
GMP certification for manufacturing facilities is a key component in verifying the integrity of dietary supplements and mitigating contamination risks. Onsite audits ensure there are appropriate procedures and training in place to consistently make supplements, but it is important to realize that it doesn't include any testing. Third-party certifications add a testing component that verifies the quality and integrity of supplement products after they are produced. Data has shown that supplements do not always meet label claims or may be contaminates with environmental contaminants like heavy metals, or with drugs and banned substances in sport. Only finished product testing can mitigate those risks.
YouTube Channel
Oliver Catlin Interview
BSCG BLOG
DOD Prohibited Dietary Supplement Ingredients: Your Guide to the List
The Catlin Perspective blog widget
THE HISTORY OF BSCG